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Novel 16S rRNA Methyltransferase RmtH Produced by Klebsiella
pneumoniae Associated with War-Related Trauma
Jessica A. O’Hara,a Patrick McGann,b Erik C. Snesrud,b Robert J. Clifford,b Paige E. Waterman,b Emil P. Lesho,b Yohei Doia
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USAa; Multidrug-resistant Organism Repository and Surveillance
Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USAb
Klebsiella pneumoniae strain MRSN2404 was isolated from the chronic wound of a soldier who had been wounded in Iraq in
2006. The strain displayed very high MICs of all aminoglycosides, including arbekacin. A gene encoding a novel 16S rRNA
methyltransferase, now designated RmtH, was identified. RmtH had 64% identity with RmtB1 and RmtB2. rmtH was bracketed
by two copies of ISCR2, which may have played a role in its mobilization.
Aminoglycosides, along with -lactams and fluoroquinolones,remain one of the key classes of antimicrobial agents in the
treatment of infections caused by Gram-negative bacteria. Mech-
anisms of resistance to aminoglycosides include enzymatic mod-
ification of the drugs, modification of the aminoglycoside-bind-
ing site, decreased permeability across the bacterial outer
membranes, and augmented efflux. Among them, production of
acquired 16S rRNA methyltransferase (16S RMTase) is the most
worrisome since it compromises the activity of all aminoglyco-
sides (1). Since the initial reports in 2003, nine such enzymes have
been identified (1, 2, 18). With the exception of NpmA, which
methylates residue A1408 of the 16S rRNA, they methylate residue
G1405 and confer high-level resistance to all aminoglycosides for-
mulated for intravenous use, including gentamicin, tobramycin,
amikacin, and arbekacin. Among the G1405 16S RMTases, ArmA
and RmtB appear to be the most widely distributed worldwide,
having been found in multiple species of the Enterobacteria-
ceae, as well as Pseudomonas aeruginosa and Acinetobacter bau-
mannii. Production of 16S RMTases is frequently accompanied
by coproduction of a carbapenemase or extended-spectrum
-lactamase (ESBL), which further facilitates multidrug resis-
tance. In the United States, the most commonly encountered 16S
RMTase is ArmA, produced by multidrug-resistant (MDR) and
extensively drug-resistant (XDR) A. baumannii, whereas the pres-
ence of RmtB and RmtE has been reported for rare strains of
Escherichia coli.
In this article, we describe identification of RmtH, a novel 16S
RMTase, in a clinical strain of Klebsiella pneumoniae. K. pneu-
moniae MRSN2404 was recovered from a 28-year-old male soldier
who had suffered a tibial fracture from an explosion in Iraq in
2006. The strain was collected by the Multidrug-resistant Organ-
ism Repository and Surveillance Network (MRSN) to enhance
infection prevention, inform empirical therapy, and influence
policy (3). Following evacuation to the United States, a culture
from the intramedullary wound of the right tibia grew XDR A.
baumannii, ESBL-producing K. pneumoniae, and vancomycin-re-
sistant enterococci. Subsequently, the patient had chronic drain-
ing wounds associated with the blast injury that occasionally ex-
pressed shrapnel. K. pneumoniae MRSN2404 was then isolated
from the wound in 2009. This strain was found to have very high
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FIG 1 Phylogenetic tree of G1405 16S RMTases. The tree was generated using
the tools available at http://www.phylogeny.fr (17). GenBank references are as
follows: ArmA, AY220558; RmtA, AB120321; RmtB1, AB103506; RmtB2,
JN968578; RmtC, AB194779; RmtD1, DQ914960; RmtD2, HQ401565; RmtE,
GU201947; RmtF, JQ808129; RmtG, JX486113.
TABLE 1 MICs of aminoglycosides
Strain
MIC (g/ml)
Gentamicin Tobramycin Amikacin
K. pneumoniae MRSN2404 256 256 256
E. coli DH10B(pKp2404K1) 256 256 256
E. coli DH10B(prmtHBX7) 256 256 256
E. coli DH10B(pBC-SK()) 0.25 0.5 1
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FIG 2 Amino acid sequence alignment of G1405 16S RMTases. The alignment was generated using the ClustalW software program (www.ebi.ac.uk/Tools
/msa/clustalw2/).
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MICs (256 g/ml) of all aminoglycosides tested, including gen-
tamicin, tobramycin, amikacin, and arbekacin, when tested by the
standard broth microdilution method recommended by the Clin-
ical and Laboratory Standards Institute (4). It was also resistant to
ceftriaxone, ceftazidime, cefepime, aztreonam, and ciprofloxacin
but remained susceptible to ertapenem and imipenem. The strain
was phenotypically confirmed as an ESBL producer, and screening
of -lactamase genes with PCR and sequencing showed that it
carried blaCTX-M-15 as well as blaSHV-1 and blaOXA-1. Multilocus
sequence typing (www.pasteur.fr/mlst) (5) assigned the strain to
sequence type (ST) 48, an ST which has been reported in associa-
tion with ESBL production worldwide (6–10).
Given the resistance phenotype consistent with 16S RMTase
production, the strain was screened for 16S RMTase genes using
PCR (2, 11, 12). However, PCR was negative for all known 16S
RMTase genes. We therefore proceeded with further experiments
to identify the determinant of high-level aminoglycoside resis-
tance. The genomic DNA of K. pneumoniae MRSN2404 was ex-
tracted, digested with KpnI (New England BioLabs, Ipswich, MA),
and ligated with the vector pBC-SK() (Agilent Technologies,
Santa Clara, CA), which had been digested with the same enzyme.
Electrocompetent Escherichia coli DH10B was transformed with
this genomic library, and transformants were selected on tryptic
soy agar (TSA) plates containing chloramphenicol (30 g/ml)
and gentamicin (50 g/ml). This procedure yielded a single
colony, which was cross-resistant to other aminoglycosides as
well. The recombinant plasmid harbored by this transformant
(pKp2404K1) was then fully sequenced. The sequencing revealed
the presence of a 3.1-kb insert, which contained an open reading
frame (ORF) corresponding to a 252-amino-acid sequence. This
ORF showed 64% amino acid identity with the 16S RMTases
RmtB1 and RmtB2 and 63% identity with RmtA. Identity with
other 16S RMTases was much lower, ranging from 25% with
ArmA to 39% with RmtD1, RmtD2, and RmtF (Fig. 1). The ORF
was designated rmtH according to the proposed nomenclature of
acquired 16S RMTases (13). We then performed PCR cloning of
rmtH using the primers rmtH-XbaI-fwd (5=-CGCTCTAGAATG
ACCATTGAACAGGCAGC-3=) and rmtG-BamHI-rev (5=-CGC
GGATCCTCAAGCTGGGTTTGGCTGGA-3=) (the restriction
sites are underlined). The PCR product was digested with XbaI
and BamHI and ligated with pBC-SK() digested with the same
enzymes. Transformants were obtained using the method above.
A transformant harboring a recombinant plasmid with the intact
rmtH structural gene (prmtHBX7), as confirmed by sequencing,
was used for susceptibility testing. Susceptibility testing was per-
formed using Etest (bioMérieux, Hazelwood, MO) according to
the manufacturer’s instructions. As shown in Table 1, the original
genomic clone, as well as the PCR clone, showed high-level resis-
tance to gentamicin, tobramycin, and amikacin, as expected.
Based on the pattern of aminoglycoside resistance and the amino
acid alignment with known 16S RMTases, RmtH likely functioned
as a G1405 16S RMTase (Fig. 2).
The full sequence of pKp2404K1 revealed that rmtH was brack-
eted by two copies of ISCR2 in tandem. ISCR2 is an IS91-like
transposable element which is found in association with various
resistance genes, including those for sulfonamide, trimethoprim,
and florfenicol (14), and also tetracycline and cephalosporin (15,
16). It is believed to facilitate mobilization of the genetic elements
downstream. To our knowledge, this is the first instance where a
16S RMTase gene was found in association with ISCR2. ISCR2 is
usually found intact upstream of a resistance gene, while the sec-
ond copy downstream is typically truncated (14). Since ISCR2
possesses a KpnI restriction site, we were not able to assess whether
the two copies of ISCR2 were intact or not. Nonetheless, this
unique arrangement suggested that they likely played a role in the
initial mobilization of rmtH to K. pneumoniae MRSN2404.
Attempts to mobilize rmtH to E. coli by either transformation
or conjugation were not successful. DNA hybridization of S1 nu-
clease-treated genomic DNA separated by pulsed-field gel electro-
phoresis (PFGE) with an rmtH-specific probe did not yield any
band despite the presence of multiple plasmids on the PFGE gel.
Finally, the rmtH probe hybridized to an approximately 500-kb
band which was generated by PFGE following XbaI digestion
(data not shown). These findings suggested that rmtH was likely
located on the chromosome.
In summary, we report a novel 16S RMTase, RmtH, identified
in an ESBL-producing K. pneumoniae strain which was recovered
from a soldier who had been wounded during an operation in
Iraq. The finding underscores the diversity of 16S RMTases and
highlights the importance of continued surveillance in identifying
emerging antimicrobial resistance mechanisms.
Nucleotide sequence accession number. The nucleotide se-
quence reported in this study has been submitted to the GenBank
under accession number KC544262.
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